IVF with Preimplantation Genetic Testing (PGT)

Selection of the most appropriate embryo to be transferred to achieve a healthy live birth through in vitro fertilization treatments is one of the most important steps of assisted reproductive techniques. Achieving higher rates of healthy live births has become possible, especially by improving the selection criteria of the embryos to be transferred. With Preimplantation Genetic Tests (PGT), it is possible to identify embryos with healthy chromosome structures and prevent unnecessary embryo transfer that may result in implantation failure or miscarriage.

Preimplantation genetic testing (PGT) is a technique in which one or more cells are taken from an embryo (fertilized egg) for testing to have information about the genetic make-up of the embryo. It is done in a lab and used in conjunction with in vitro fertilization (IVF).

PGT is a new term in fertility medicine that replaces the more familiar terms of preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS), while serving the same functions as those screenings.

Preimplantation genetic testing has three types of screenings as listed below.

Preimplantation genetic testing (PGT) screens embryos created through in vitro fertilization (IVF) for genetic and chromosome abnormalities before they are transferred to the uterus. For this reason, PGT increases the chance of IVF success and the probability of having a healthy baby.

Preimplantation genetic testing can be considered if;

Sex selection allows couples to prevent the transmission of sex-linked genetic disorders such as hemophilia, muscular dystrophy and fragile-X syndrome and to choose female or unaffected male embryos in order to prevent the risk of these genetic disorders in their children.

Patients may be interested in selecting the sex of their child to “balance” the number of girls or boys in their families.

Sex selection, also known as gender selection or family balancing, is the process of determining the gender (male or female) of each embryo created through in vitro fertilization (IVF).

The gender identification of embryos is done using preimplantation genetic testing (PGT), which involves taking a few cells from an embryo on the 3rd or 5th day after embryo creation, and determining the sex of the embryos through genetic analysis.

After testing, only the healthy embryos are implemented to woman’s uterus during an embryo transfer procedure.

Your IVF journey begins with a consultation with one of our fertility experts, where we’ll discuss and assess your fertility status by reviewing your and your partner’s most recent blood tests and health reports and creating a customised plan for you.

Our embryologists fertilise the collected eggs with your partner’s sperm. We use the ICSI method for the fertilisation procedure, injecting the selected sperm directly into the egg.

After fertilisation, the embryos will be kept in a particular culture medium in the laboratory for five days. Following embryo creation, preimplantation genetic testing will be performed on 3rd or 5th day by taking a biopsy from each embryo.

The healthy and highest-quality embryos are selected and transferred into the uterus at the end of the laboratory process. The number of embryos to be transferred is decided by our doctor with you, considering your age, general health, previous unsuccessful IVF attempts and the quality of the embryos. (If more than one embryo is transferred, the possibility of multiple pregnancies increases.) Based on the regulation in North Cyprus, we are allowed to transfer a maximum of three embryos at one transfer.

After one or two healthy embryos are transferred into the uterus, the remaining embryos are frozen for future use on the same day of embryo transfer.

In this way, your IVF cycle is completed. You will perform a pregnancy blood test after 12 days after the embryo transfer date and let us know the result.